{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T07:21:58Z","timestamp":1773300118515,"version":"3.50.1"},"reference-count":28,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2007,9,17]],"date-time":"2007-09-17T00:00:00Z","timestamp":1189987200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Nephrology"],"published-print":{"date-parts":[[2008,2]]},"abstract":"<jats:title>SUMMARY:<\/jats:title><jats:p><jats:bold>Background:\u2003<\/jats:bold> An adequate total body pool of ascorbate is essential for optimum health in humans. Requirements for ascorbate are increased in peritoneal dialysis (PD) patients most likely due to a combination of poor nutrition and increased dialysate losses.<\/jats:p><jats:p><jats:bold>Methods:\u2003<\/jats:bold> We measured serum ascorbate levels in 45 clinically stable PD patients to assess the prevalence of ascorbate insufficiency (level between 2 and 4\u2003mg\/L) and deficiency (level &lt;2\u2003mg\/L). We also assessed the efficacy of subsequent supplementation and patients' adherence to the prescribed supplementation. All patients were advised on commencement of dialysis to take a multivitamin tablet containing 100\u2013120\u2003mg ascorbate.<\/jats:p><jats:p><jats:bold>Results:\u2003<\/jats:bold> Eighteen (41%) PD patients were regularly taking ascorbate\u2010containing multivitamins, while 27 (59%) patients did not take ascorbate supplements. Serum ascorbate levels ranged from &lt;0.2 to 41\u2003mg\/L, with wide variations in serum ascorbate at any given intake level. Ascorbate deficiency was present in 1\/3 of the current PD population (44% of patients not taking supplements and in 16% of those on supplements), although none of the patients demonstrated clinical manifestations of scurvy. Targeted supplementation of ascorbate insufficient patients increased the median serum ascorbate level from 1.7\u2003mg\/L (IQR 1.2\u20132.2) to 22.5\u2003mg\/L (IQR 16.7\u201332.9).<\/jats:p><jats:p><jats:bold>Conclusion:\u2003<\/jats:bold> Our results show that, in PD patients, ascorbate deficiency is common and can readily be identified with serum ascorbate measurements. Oral supplements in the form of inexpensive multivitamin preparations restore adequate serum ascorbate levels in the majority of these patients. We therefore suggest measurement of ascorbate levels in all PD patients at the commencement of dialysis with a target level in the normal range (4\u201314\u2003mg\/L).<\/jats:p>","DOI":"10.1111\/j.1440-1797.2007.00857.x","type":"journal-article","created":{"date-parts":[[2007,9,19]],"date-time":"2007-09-19T04:30:14Z","timestamp":1190176214000},"page":"17-22","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["High prevalence of ascorbate deficiency in an Australian peritoneal dialysis population"],"prefix":"10.1111","volume":"13","author":[{"given":"RICHARD","family":"SINGER","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"HELEN C","family":"RHODES","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"GEORGE","family":"CHIN","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"HEMANT","family":"KULKARNI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"PAOLO","family":"FERRARI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2007,9,17]]},"reference":[{"key":"e_1_2_6_2_2","unstructured":"KallnerA.Influence of vitamin C status on the urinary excretion of catecholamines in stress.Hum. Nutr. Clin. Nutr.1983;37:405\u201311."},{"key":"e_1_2_6_3_2","doi-asserted-by":"crossref","unstructured":"PadhH.Vitamin C: Newer insights into its biochemical functions.Nutr. Rev.1991;49:65\u201370.","DOI":"10.1111\/j.1753-4887.1991.tb07407.x"},{"key":"e_1_2_6_4_2","doi-asserted-by":"crossref","unstructured":"PetersEM AndersonR. NiemanDC FicklH JogessarV.Vitamin C supplementation attenuates the increases in circulating cortisol adrenaline and anti\u2010inflammatory polypeptides following ultramarathon running.Int. J. Sports Med.2001;22:537\u201343.","DOI":"10.1055\/s-2001-17610"},{"key":"e_1_2_6_5_2","doi-asserted-by":"crossref","unstructured":"PatakP WillenbergHS BornsteinSR.Vitamin C is an important cofactor for both adrenal cortex and adrenal medulla.Endocr. Res.2004;30:871\u20135.","DOI":"10.1081\/ERC-200044126"},{"key":"e_1_2_6_6_2","doi-asserted-by":"crossref","unstructured":"BakerEM HodgesRE HoodJ SauberlichHE MarchSC CanhamJE.Metabolism of 14C\u2010 and 3H\u2010labeled 1\u2010ascorbic acid in human scurvy.Am. J. Clin. Nutr.1971;24:444\u201354.","DOI":"10.1093\/ajcn\/24.4.444"},{"key":"e_1_2_6_7_2","doi-asserted-by":"crossref","unstructured":"ReulerJB BroudyVC CooneyTG.Adult scurvy.JAMA1985;253:805\u20137.","DOI":"10.1001\/jama.253.6.805"},{"key":"e_1_2_6_8_2","doi-asserted-by":"crossref","unstructured":"HodgesRE BakerEM HoodJ SauberlichHE MarchSC.Experimental scurvy in man.Am. J. Clin. Nutr.1969;22:535\u201348.","DOI":"10.1093\/ajcn\/22.5.535"},{"key":"e_1_2_6_9_2","doi-asserted-by":"crossref","unstructured":"HodgesRE HoodJ CanhamJE SauberlichHE BakerEM.Clinical manifestations of ascorbic acid deficiency in man.Am. J. Clin. Nutr.1971;24:432\u201343.","DOI":"10.1093\/ajcn\/24.4.432"},{"key":"e_1_2_6_10_2","doi-asserted-by":"crossref","unstructured":"LevineM Conry\u2010CantilenaC WangYet\u2003al.Vitamin C pharmacokinetics in healthy volunteers: Evidence for a recommended dietary allowance.Proc. Natl. Acad. Sci. U.S.A.1996;93:3704\u20139.","DOI":"10.1073\/pnas.93.8.3704"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1056-8727(97)00125-6"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1525-1594.1998.06220.x"},{"key":"e_1_2_6_13_2","first-page":"219","article-title":"Serum ascorbic acid and protein calorie malnutrition in continuous ambulatory peritoneal dialysis patients","volume":"17","author":"Lee EJ","year":"2001","journal-title":"Adv. Perit. Dial."},{"key":"e_1_2_6_14_2","first-page":"215","article-title":"Oral intake and serum levels of ascorbic acid in continuous ambulatory peritoneal dialysis patients","volume":"17","author":"Lim SL","year":"2001","journal-title":"Adv. Perit. Dial."},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0272-6386(12)80295-2"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1159\/000183353"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.2001.07847.x"},{"key":"e_1_2_6_18_2","first-page":"181","article-title":"Plasma concentration and peritoneal clearance of oxalate in patients on continuous ambulatory peritoneal dialysis (CAPD)","volume":"25","author":"Yamauchi A","year":"1986","journal-title":"Clin. Nephrol."},{"key":"e_1_2_6_19_2","first-page":"28","article-title":"Oxalate metabolism in end\u2010stage renal disease: The effect of ascorbic acid and pyridoxine","volume":"3","author":"Morgan SH","year":"1988","journal-title":"Nephrol. Dial Transplant"},{"key":"e_1_2_6_20_2","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1681\/ASN.V1121289","article-title":"Plasma oxalate levels rise in hemodialysis patients despite increased oxalate removal","volume":"1","author":"Costello JF","year":"1991","journal-title":"J. Am. Soc. Nephrol."},{"key":"e_1_2_6_21_2","first-page":"58","article-title":"Oxalosis in hemodialysis patients: A pathologic study of 80 cases","volume":"103","author":"Fayemi AO","year":"1979","journal-title":"Arch. Pathol. Laboratory Med."},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/0009-8981(89)90007-7"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0272-6386(12)80271-X"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.35.10.1466"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1258\/000456302320314566"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02085415"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2230.1985.tb00603.x"},{"key":"e_1_2_6_28_2","first-page":"E467","article-title":"Oral mucosa symptoms, signs and lesions, in end stage renal disease and non\u2010end stage renal disease diabetic patients","volume":"11","author":"De La Rosa Garcia E","year":"2006","journal-title":"Med. Oral Patol. Oral Cir. Bucal."},{"key":"e_1_2_6_29_2","first-page":"153","article-title":"Incidence of gingival hyperplasia caused by calcium antagonists in continuous ambulatory peritoneal dialysis patients","volume":"15","author":"Shouda J","year":"1999","journal-title":"Adv. Perit. Dial."}],"container-title":["Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1440-1797.2007.00857.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1440-1797.2007.00857.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,10]],"date-time":"2023-10-10T05:42:23Z","timestamp":1696916543000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1440-1797.2007.00857.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,9,17]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,2]]}},"alternative-id":["10.1111\/j.1440-1797.2007.00857.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1440-1797.2007.00857.x","archive":["Portico"],"relation":{},"ISSN":["1320-5358","1440-1797"],"issn-type":[{"value":"1320-5358","type":"print"},{"value":"1440-1797","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,9,17]]},"assertion":[{"value":"2007-09-17","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}